Dr. Tay has researched antibodies and diseases like malaria and SARS-CoV-2 at A*STAR, first at the Singapore Immunology Network (SIgN) and later at the A*STAR Infectious Diseases Labs (A*STAR ID Labs). His focus is on discovering methods for developing antibodies against multidrug-resistant pathogens.
He studies the antimicrobial functions of antibodies to help improve the effectiveness of antibody-based diagnostics and therapeutics against both current and emerging pathogens. His lab investigates how each antibody’s antimicrobial functions relate to its mode of interaction with its target, allowing the discovery of potential targets critical to an effective vaccine.
